IL33393A - History of Coinazoline - Google Patents

History of Coinazoline

Info

Publication number
IL33393A
IL33393A IL33393A IL3339369A IL33393A IL 33393 A IL33393 A IL 33393A IL 33393 A IL33393 A IL 33393A IL 3339369 A IL3339369 A IL 3339369A IL 33393 A IL33393 A IL 33393A
Authority
IL
Israel
Prior art keywords
quinazoline
dimethyl
tetrahydr0
tetrahydro
difference
Prior art date
Application number
IL33393A
Other languages
English (en)
Hebrew (he)
Other versions
IL33393A0 (en
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Publication of IL33393A0 publication Critical patent/IL33393A0/xx
Publication of IL33393A publication Critical patent/IL33393A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL33393A 1968-11-26 1969-11-21 History of Coinazoline IL33393A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2416068 1968-11-26

Publications (2)

Publication Number Publication Date
IL33393A0 IL33393A0 (en) 1970-01-29
IL33393A true IL33393A (en) 1973-04-30

Family

ID=11212294

Family Applications (1)

Application Number Title Priority Date Filing Date
IL33393A IL33393A (en) 1968-11-26 1969-11-21 History of Coinazoline

Country Status (16)

Country Link
US (1) US3660322A (US20110009641A1-20110113-C00116.png)
AT (1) AT290542B (US20110009641A1-20110113-C00116.png)
BE (1) BE742205A (US20110009641A1-20110113-C00116.png)
BR (1) BR6914433D0 (US20110009641A1-20110113-C00116.png)
CH (1) CH523892A (US20110009641A1-20110113-C00116.png)
DE (1) DE1958515B2 (US20110009641A1-20110113-C00116.png)
DK (1) DK123239B (US20110009641A1-20110113-C00116.png)
ES (1) ES373909A1 (US20110009641A1-20110113-C00116.png)
FR (1) FR2024241B1 (US20110009641A1-20110113-C00116.png)
GB (1) GB1231959A (US20110009641A1-20110113-C00116.png)
IE (1) IE33406B1 (US20110009641A1-20110113-C00116.png)
IL (1) IL33393A (US20110009641A1-20110113-C00116.png)
NL (1) NL147140B (US20110009641A1-20110113-C00116.png)
NO (1) NO123430B (US20110009641A1-20110113-C00116.png)
SE (1) SE360659B (US20110009641A1-20110113-C00116.png)
YU (1) YU33286B (US20110009641A1-20110113-C00116.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31617E (en) * 1972-02-04 1984-06-26 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
DE3815767A1 (de) * 1988-05-09 1989-11-23 Karl Niggemeier Abhefter fuer einzelblaetter
KR950701322A (ko) * 1992-05-07 1995-03-23 조셉 에프. 디프리마 사람면역결핍바이러스 역전사효소의 억제제로서의 신규한 퀴나졸린(New quinazolines as inhibitors of HIV reversetranscriptase)
US6124302A (en) 1997-04-09 2000-09-26 Dupont Pharmaceuticals 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors
CA2322203A1 (en) * 1998-03-27 1999-10-07 Jeffrey W. Corbett 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors

Also Published As

Publication number Publication date
IE33406L (en) 1970-05-26
SE360659B (US20110009641A1-20110113-C00116.png) 1973-10-01
DK123239B (da) 1972-05-29
FR2024241A1 (US20110009641A1-20110113-C00116.png) 1970-08-28
NL147140B (nl) 1975-09-15
FR2024241B1 (US20110009641A1-20110113-C00116.png) 1973-07-13
ES373909A1 (es) 1972-08-16
YU292269A (en) 1976-03-31
IL33393A0 (en) 1970-01-29
US3660322A (en) 1972-05-02
AT290542B (de) 1971-06-11
GB1231959A (US20110009641A1-20110113-C00116.png) 1971-05-12
CH523892A (de) 1972-06-15
DE1958515B2 (de) 1976-06-24
DE1958515A1 (de) 1970-07-09
BE742205A (US20110009641A1-20110113-C00116.png) 1970-05-25
IE33406B1 (en) 1974-06-12
NL6917085A (US20110009641A1-20110113-C00116.png) 1970-05-28
YU33286B (en) 1976-08-31
NO123430B (US20110009641A1-20110113-C00116.png) 1971-11-15
BR6914433D0 (pt) 1973-02-22

Similar Documents

Publication Publication Date Title
GB2157289A (en) Oxazino-and thiazinoisoquinolines
DE1670523A1 (de) Verfahren zur Herstellung neuer substituierter Aminopyridine
IL33393A (en) History of Coinazoline
CH621772A5 (US20110009641A1-20110113-C00116.png)
DE1934809A1 (de) Neue Hydrazon-N-dithiocarbonsaeureester und Verfahren zur Herstellung derselben
DE1470070B1 (de) Verfahren zur Herstellung von Benzimidazolderivaten
CS207603B2 (en) Method of making the 1,3-disubstituated ureas or 1,3-disubstituted/2-thio/ureas
DE2031826C3 (de) Verfahren zur N-Acylierung von Aminogruppen enthaltenden anorganischen oder organischen Verbindungen
PL114759B1 (en) Process for preparing novel 3-di-n-propyloacetoxybenzodiazepin-2-ones
US2748129A (en) Sulfamylpiperazines and method of preparing the same
US3180793A (en) Insect sterilizing process
DE2214488C3 (de) Verfahren zur Herstellung 1-substituierter 4-AminopyiTolin-3-one(2)
AT231455B (de) Verfahren zur Herstellung von neuen Diazepinderivaten
DE1923139C2 (de) Benzodiazepin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE957573C (de) Verfahren zur Herstellung von Abkoemmlingen von 10-(Aminoalkyl)-acridanen
US3437689A (en) Aromatic amino acid
US2839527A (en) Sulfanilamido isoxazole derivatives
CH634835A5 (de) Verfahren zur herstellung von neuen benzodiazepinderivaten.
US3288807A (en) Diphosphoranylideneamino derivatives of maleimides
AT270647B (de) Verfahren zur Herstellung neuer substituierter Aminopyridine, von deren Salzen und optisch aktiven Isomeren
DE1670258A1 (de) Verfahren zur Entalkylierung cyclischer N-Alkyl-aminoverbindungen
DE1219029B (de) Verfahren zur Herstellung von neuen Zinnkomplexsalzen
DE1184344B (de) Verfahren zur Herstellung von Isochinolinderivaten
DE1545842B2 (de) Verfahren zur Herstellung von N-substituierten 3-Halogen-benzisothiazoliumhalogeniden
DD295360A5 (de) Verfahren zur Herstellung von aktivierten Carbonsäureestern